Epidermolysis bullosa simplex with circinate migratory erythema

Epidermolysis bullosa simplex with circinate migratory erythema (EBS-migr) is an extremely rare subtype of epidermolysis bullosa simplex, a group of inherited skin fragility disorders. This condition is caused by mutations in the KRT5 gene, which encodes keratin 5, a structural protein essential for the integrity of the basal layer of the epidermis. The disease is characterized by the formation of skin blisters upon minor mechanical trauma, combined with a distinctive pattern of circinate (ring-shaped) and migratory erythematous (red) patches that move across the skin surface over time. These erythematous lesions are a hallmark feature that distinguishes this subtype from other forms of epidermolysis bullosa simplex. The skin is the primary organ system affected. Patients typically present with widespread blistering that may be present from birth or early infancy, along with the characteristic migratory red rings or arcs on the trunk and extremities. Blisters heal without significant scarring, as the cleavage plane is within the epidermis (intraepidermal). Nail dystrophy and milia (small white cysts) may also be observed in some patients. The erythematous patches can wax and wane and may be associated with a burning sensation. There is currently no cure for EBS with circinate migratory erythema. Treatment is supportive and focuses on wound care, prevention of blister formation by minimizing skin trauma, infection prevention, and pain management. Protective padding and appropriate wound dressings are used to manage blisters. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, management is best guided by specialists experienced in epidermolysis bullosa.

Common questions about Epidermolysis bullosa simplex with circinate migratory erythema